Nanostructures for Antiviral Therapy: In the Last Two Decades

被引:2
作者
Siddiq, Afshan [1 ]
Younus, Ishrat [2 ]
Shamim, Asma [3 ]
Badar, Sehrish [2 ]
机构
[1] Univ Karachi, Fac Pharm & Pharmaceut Sci, Dept Pharmacol, Karachi, Pakistan
[2] Hamdard Univ, Fac Pharm, Dept Pharmacol, Karachi, Pakistan
[3] Aga Khan Univ Hosp, Dept Pharm Serv, Karachi, Pakistan
关键词
Nanostructures; nanotechnology; antiviral therapy; hepatitis virus; herpes virus; HIV; SOLID LIPID NANOPARTICLES; IN-VITRO; ANTISENSE OLIGONUCLEOTIDES; HUMAN CYTOMEGALOVIRUS; POLYBUTYLCYANOACRYLATE NANOPARTICLES; CYANOACRYLATE NANOPARTICLES; LOADED NANOPARTICLES; BODY DISTRIBUTION; DELIVERY-SYSTEMS; DRUG-DELIVERY;
D O I
10.2174/1573413713666170110115736
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Viral infection is one of the global health problems and for the eradication of such infections no considerable antiviral agents are available. In addition, problem of emerging resistance to available antiviral agents is also rising day by day. The treatment of viral infection is indeed more complicated contrary to bacterial infection. So there is a dire need of identifying new type and technology to design dosage forms for antiviral drugs. In current scientific world, research works on Nanostructured particles are of huge significance because of its vital use in different fields of medical sciences and technology like biomedical, electronic and optical fields. Methods: Research works and online contents related to nanostructures and nanotechnology that were designed for the advancement and effectiveness in antiviral therapy in the last two decades has been reviewed and presented in a summarized form. The efforts of scientists in the field of nanotechnology based antiviral drug design are written precisely to guide research workers, students and health care professionals. Results: Regarding viral infections, identification of numerous nanostructured particles has been done. In last two decades, these particles have been reported with some potential activities against different viruses and exhibits potent role in preventing and curing different viral infections. Conclusion: The antiviral systems based on nanotechnology can be designed with different and advanced functions like they might possess a different mechanism for releasing of the drug from its dosage design, more amount of drug might be available in biological fluid, improved activity with minimum adverse reactions and cost effectivity. Further, these designs might also provide specific and targeted drug delivery to the infected sites and viral pools in the body. Extensive research on receptor-based antiviral nanoparticles is going on which could reduce toxic and harmful effects of drugs in other normal tissues and ensure availability of accurate amount of dose to the targeted area.
引用
收藏
页码:229 / 246
页数:18
相关论文
共 80 条
[1]   Smart nanoparticles as targeting platforms for HIV infections [J].
Adhikary, Rishi Rajat ;
More, Prachi ;
Banerjee, Rinti .
NANOSCALE, 2015, 7 (17) :7520-7534
[2]   PHARMACOKINETICS OF ANTISENSE OLIGONUCLEOTIDES [J].
AGRAWAL, S ;
TEMSAMANI, J ;
GALBRAITH, W ;
TANG, JY .
CLINICAL PHARMACOKINETICS, 1995, 28 (01) :7-16
[3]   Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection [J].
Antoine, Thessicar E. ;
Mishra, Yogendra K. ;
Trigilio, James ;
Tiwari, Vaibhav ;
Adelung, Rainer ;
Shukla, Deepak .
ANTIVIRAL RESEARCH, 2012, 96 (03) :363-375
[4]   Inhibition of Herpes Simplex Virus Type 1 Infection by Silver Nanoparticles Capped with Mercaptoethane Sulfonate [J].
Baram-Pinto, Dana ;
Shukla, Sourabh ;
Perkas, Nina ;
Gedanken, Aharon ;
Sarid, Ronit .
BIOCONJUGATE CHEMISTRY, 2009, 20 (08) :1497-1502
[5]   INFLUENCE OF POLYBUTYLCYANOACRYLATE NANOPARTICLES AND LIPOSOMES ON THE EFFICACY AND TOXICITY OF THE ANTICANCER DRUG MITOXANTRONE IN MURINE TUMOR-MODELS [J].
BECK, P ;
KREUTER, J ;
RESZKA, R ;
FICHTNER, I .
JOURNAL OF MICROENCAPSULATION, 1993, 10 (01) :101-114
[6]   INHIBITION OF HIV IN-VITRO BY ANTIVIRAL DRUG-TARGETING USING NANOPARTICLES [J].
BENDER, A ;
SCHAFER, V ;
STEFFAN, AM ;
ROYER, C ;
KREUTER, J ;
RUBSAMENWAIGMANN, H ;
VONBRIESEN, H .
RESEARCH IN VIROLOGY, 1994, 145 (3-4) :215-220
[7]   Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro [J].
Bender, AR ;
vonBriesen, H ;
Kreuter, J ;
Duncan, IB ;
RubsamenWaigmann, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (06) :1467-1471
[8]  
BERTHE P, 1994, INVEST OPHTH VIS SCI, V35, P1038
[9]   Inhibition of Influenza A Virus Infection in Vitro by Saliphenylhalamide-Loaded Porous Silicon Nanoparticles [J].
Bimbo, Luis M. ;
Denisova, Oxana V. ;
Makila, Ermei ;
Kaasalainen, Martti ;
De Brabander, Jef K. ;
Hirvonen, Jouni ;
Salonen, Jarno ;
Kakkola, Laura ;
Kainov, Denis ;
Santos, Helder A. .
ACS NANO, 2013, 7 (08) :6884-6893
[10]   METABOLIC-ACTIVATION OF THE NUCLEOSIDE ANALOG 9-([2-HYDROXY-L-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE IN HUMAN-DIPLOID FIBROBLASTS INFECTED WITH HUMAN CYTOMEGALO-VIRUS [J].
BIRON, KK ;
STANAT, SC ;
SORRELL, JB ;
FYFE, JA ;
KELLER, PM ;
LAMBE, CU ;
NELSON, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (08) :2473-2477